Topical Wound Agents Market Analysis

End-user (Hospitals, Clinics); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce)

The global topical wound agents market is segmented and analyzed for demand and supply by end-user into hospitals, clinics, and others, out of which the hospitals segment is estimated to hold the largest share over the forecast period on the back of a growing count of patients’ hospitalization who is suffering from chronic and acute wounds. Since a large number of countries are paying adequate attention to the healthcare infrastructure, it becomes quite convenient to receive desired treatment. For instance, the Centers for Medicare & Medicaid Services stated that in 2020, 131.1 million hospital visits occurred in the United States, out of which 38 million were owing to injury-related visits. Furthermore, the increasing prevalence of chronic wounds including venous leg ulcers, infectious wounds, ischemic wounds, surgical wounds, and wounds from radiation poisoning which need specialized treatment is allowing the population to opt for hospital and its technologically advanced products are anticipated to boost a significant revenue generation of the segment.

Application {Acute Wound (Surgical & Traumatic Wound, Burns)

The global topical wound agents market is also segmented and analyzed for demand and supply by application to acute wounds and chronic wounds. Out of these, the chronic wound segment is forecasted to hold the largest share of the market. The major factor attributed to the growth is the increased prevalence of chronic diseases such as diabetes, obesity, and others which leads to chronic wounds including diabetic foot ulcers, venous leg ulcers, and many more. Topical wound agents are effective medical products that heal chronic wounds in a painless way. Also, the rising cases of surgical procedures, traumatic incidents, and accidents are anticipated to rise the number of chronic diseases which ultimately generates a high demand for topical wound agents.

Our in-depth analysis of the global market includes the following segments:

By Product Type	Creams Gels Powders Lotions Emulsions Others
By Application	Acute Wound Surgical & Traumatic Wound Burns Chronic Wound Diabetic Foot Ulcer Venous Leg Ulcer Pressure Ulcer Others
By End-User	Hospitals Clinics Others
By Distribution Channel	Hospital Pharmacies Retail Pharmacies E-Commerce

Frequently Asked Questions (FAQ)

Growing prevalence of chronic wounds, the increasing number of diabetic foot ulcers, the surge in burns cases, and the escalation in post-surgical wounds are some of the major factors estimated to drive the growth of the market.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2033.

High cost of chronic wound treatment, the rising tendency in patients for urgent treatment, and competitive pricing of topical treatment products among manufacturers are some of the factors estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Smith & Nephew PLC, MÃ¶lnlycke Health Care AB, Novartis Pharma AG, Pfizer Inc., Johnson & Johnson Services, Inc., Viatris Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Coloplast A/S, ConvaTec Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, distribution channel, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Topical Wound Agents Market Analysis